bromantane vs semax
bromantane (B-tier) vs semax (B-tier). mechanism, trials, claims vs data, dosing literature. side-by-side reference.
bromantane — tier B
a Russian antiasthenic CNS drug with older human studies in illness-related fatigue, incomplete modern replication, no traceable primary human half-life source, and in-competition WADA prohibition.
bromantane has a real Russian drug and human-study record for asthenia, but that record does not establish healthy cognitive enhancement, long-term safety, or the internet's preferred half-life number.
728 patients in the largest indexed Russian asthenia study · half-life not structured; the repeated 11.21-hour human claim was not traced to an accessible primary PK source · focus
semax — tier B
russian nootropic. approved there, not here. for focus, stroke recovery, and cognitive decline. real mechanism, thin US trials.
Russian nootropic. approved there since the 1990s. BDNF upregulation within 30 minutes of an intranasal dose, effect persists 24+ hours.
Russia '82 stroke registry · half-life minutes in plasma; effects persist for hours due to CNS penetration and BDNF induction cascade · focus
at a glance
- bromantane: tier B · 728 patients in the largest indexed Russian asthenia study
- semax: tier B · Russia '82 stroke registry
reptides grades the research record and cites the literature behind every call. research reference only; not medical advice.
